Leading generics pharmaceutical company
Corporate News
Latest Mediscor review says generic utilisation rate more than doubled from 27.7% in 2002 to 62.4% in 2018 The use of cheaper generic alternatives that are no longer patent-protected rose to an all-time high in the private sector in 2018, according to the latest Mediscor review. The trend highlights the continued impact of the […]
As per the study conducted by Journal of Drug Delivery and Therapeutics, about 62% of healthcare providers want to substitute generic drugs but not for all the cases they treat, thus indicates the perception of the efficacy of the two classes of medicines. With the escalating cost of healthcare facilities, many people in India […]
Medicare could have saved nearly 90% of spending on angiotensin converting enzyme inhibitors and angiotensin-II-receptor blockers in 2016 and 2017 through generic substitute or therapeutic interchange, according to study results published in JAMA Internal Medicine. “Prescription drug spending accounts for an increasing share of U.S. health care costs.” Mathew E. Growdon, MD, MPH, of the […]
Effective 1 July 2019, the EU adopted a regulation by introducing a supplementary protection certificate (SPC) manufacturing and stockpiling waiver. This waiver also applies for biosimilar versions of SPC-protected medicine during the term of the SPC. SPC’s are defined as IP rights extending patent protection for up to five years for medicines that are […]
“Costly branded medicines are a factor in driving up the cost of insurance”! Expensive branded medicines prescribed by doctors are driving up the cost of healthcare for insurers and employers, experts have said. Insurers said too many physicians are sending patients home with bags of unnecessary drugs. The issue is a factor in a new […]
It’s pretty much just two women who name the 200-plus drugs that come out every year Generic prescriptions allow patients to get the medicines they need at a lower price, without sacrificing the quality of treatment because, as we know, generic drugs are required by the FDA to be nearly identical to their name-brand […]
According to the Association for Accessible Medicines 2019 report with data from IQVIA, generic drug savings totaled $293 billion in 2018, which resulted in a 10-year savings of almost $2 trillion. Other key findings include that 4 billion generic prescriptions were filled across the U.S. in 2018, which is 90% of all dispensed prescriptions. Additionally, 95% of […]
According to the World Health Organization, sham drugs are the world’s most lucrative counterfeit goods, with a global market worth roughly $200bn, and Africa accounts for around 42% of the world’s cases. But what is behind this scourge, and what can be done to stop it? Abi Miller finds out. Counterfeit drugs are a deadly, […]
Ranitidine is a commonly prescribed medicine for countering acidity and is on the WHO’s Model List of Essential Medicines. Amid a raging controversy over commonly used heartburn drug Ranitidine, Mumbai-based Taj Pharmaceuticals Limited today said that its formulation drug is safe. The company said that the test results found that Taj Pharmaceuticals’ Ranitidine tablets was within […]
Dexamethasone is a type of corticosteroid medication manufactured by Taj Pharmaceuticals India. It is used in the treatment of many conditions, including COVID-19 respiratory side effects, rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling, eye pain following eye surgery, and along with antibiotics in tuberculosis. In adrenocortical insufficiency, it should be used together with a medication that has greater mineralocorticoid effects such as fludrocortisone.[1] In preterm labor, it may be used to improve outcomes in the baby. It may be taken by mouth, as an injection into a muscle, or intravenously. The effects of dexamethasone are frequently seen within a day and last for about three days.
